2885-01-0 Usage
General Description
Butyl glycinate, also known as N-butylglycine, is a chemical compound with the molecular formula C6H13NO2. It is a derivative of glycine, an amino acid that serves as a building block for proteins in the human body. Butyl glycinate is commonly used as a cosmetic ingredient, particularly in skincare products, due to its moisturizing and conditioning properties. It functions as a humectant, helping to retain moisture in the skin and hair. Additionally, butyl glycinate is also used in the production of pharmaceuticals and as a potential ingredient in the synthesis of new drugs. Its versatile properties make it a valuable compound in the chemical and beauty industries. However, it is important to use butyl glycinate in moderation, as excessive exposure may cause skin irritation or allergic reactions.
Check Digit Verification of cas no
The CAS Registry Mumber 2885-01-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,8,8 and 5 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 2885-01:
(6*2)+(5*8)+(4*8)+(3*5)+(2*0)+(1*1)=100
100 % 10 = 0
So 2885-01-0 is a valid CAS Registry Number.
InChI:InChI=1/C6H13NO2/c1-2-3-4-9-6(8)5-7/h2-5,7H2,1H3
2885-01-0Relevant articles and documents
A mild removal of Fmoc group using sodium azide
Chen, Chun-Chi,Rajagopal, Basker,Liu, Xuan Yu,Chen, Kuan Lin,Tyan, Yu-Chang,Lin, Fui,Lin, Po-Chiao
, p. 367 - 374 (2014/03/21)
A mild method for effectively removing the fluorenylmethoxycarbonyl (Fmoc) group using sodium azide was developed. Without base, sodium azide completely deprotected Nα-Fmoc-amino acids in hours. The solvent-dependent conditions were carefully studied and then optimized by screening different sodium azide amounts and reaction temperatures. A variety of Fmoc-protected amino acids containing residues masked with different protecting groups were efficiently and selectively deprotected by the optimized reaction. Finally, a biologically significant hexapeptide, angiotensin IV, was successfully synthesized by solid phase peptide synthesis using the developed sodium azide method for all Fmoc removals. The base-free condition provides a complement method for Fmoc deprotection in peptide chemistry and modern organic synthesis. Graphical Abstract: [Figure not available: see fulltext.]
